The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Ganglion Cell Loss in Relation to Visual Disability in Multiple Sclerosis
Open accessAbstract
Purpose We used high-resolution spectral-domain optical coherence tomography (SD-OCT) with retinal segmentation to determine how ganglion cell loss relates to history of acute optic neuritis (ON), retinal nerve fiber layer (RNFL) thinning, visual function, and vision-related quality of life (QOL) in multiple sclerosis (MS). Design Cross-sectional study. Participants A convenience sample of patients with MS (n = 122; 239 eyes) and disease-free controls (n = 31; 61 eyes). Among MS eyes, 87 had a history of ON before enrollment. Methods The SD-OCT images were captured using Macular Cube (200×200 or 512×128) and ONH Cube 200×200 protocols. Retinal layer segmentation was performed using algorithms established for glaucoma studies. Thicknesses of the ganglion cell layer/inner plexiform layer (GCL+IPL), RNFL, outer plexiform/inner nuclear layers (OPL+INL), and outer nuclear/photoreceptor layers (ONL+PRL) were measured and compared in MS versus control eyes and MS ON versus non-ON eyes. The relation between changes in macular thickness and visual disability was also examined. Main Outcome Measures The OCT measurements of GCL+IPL and RNFL thickness; high contrast visual acuity (VA); low-contrast letter acuity (LCLA) at 2.5% and 1.25% contrast; on the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) and 10-Item Neuro-Ophthalmic Supplement composite score. Results Macular RNFL and GCL+IPL were significantly decreased in MS versus control eyes (P<0.001 and P = 0.001) and in MS ON versus non-ON eyes (P<0.001 for both measures). Peripapillary RNFL, macular RNFL, GCL+IPL, and the combination of macular RNFL+GCL+IPL were significantly correlated with VA (P≤0.001), 2.5% LCLA (P<0.001), and 1.25% LCLA (P≤0.001). Among OCT measurements, reductions in GCL+IPL (P<0.001), macular RNFL (P = 0.006), and the combination (macular RNFL+GCL+IPL; P<0.001) were most strongly associated with lower (worse) NEI-VFQ-25 and 10-Item Supplement QOL scores; GCL+IPL thinning was significant even accounting for macular RNFL thickness (P = 0.03 for GCL+IPL, P = 0.39 for macular RNFL). Conclusions We demonstrated that GCL+IPL thinning is most significantly correlated with both visual function and vision-specific QOL in MS, and may serve as a useful structural marker of disease. Our findings parallel those of magnetic resonance imaging studies that show gray matter disease is a marker of neurologic disability in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Development of the 25-list-item National Eye Institute Visual Function Questionnaire
Mangione, C. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.7.1050 · Cited by 2,230
Gray matter atrophy in multiple sclerosis: A longitudinal study
Fisher, E., Lee, J., Nakamura, K., & Rudick, R. A. (2008) · Annals of Neurology · doi:10.1002/ana.21436 · Cited by 670
Detection of Macular Ganglion Cell Loss in Glaucoma by Fourier-Domain Optical Coherence Tomography
Tan, O., Chopra, V., Lu, A. T.-H., Schuman, J. S., Ishikawa, H., Wollstein, G., Varma, R., & Huang, D. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.05.025 · Cited by 665
Self-citationRelation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
FISHER, J., JACOBS, D., MARKOWITZ, C., GALETTA, S., VOLPE, N., NANOSCHIAVI, M., BAIER, M., FROHMAN, E., WINSLOW, H., & FROHMAN, T. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.040 · Cited by 658
Self-citationOptical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
Petzold, A., de Boer, J. F., Schippling, S., Vermersch, P., Kardon, R., Green, A., Calabresi, P. A., & Polman, C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70168-x · Cited by 596
Self-citationGray matter atrophy is related to long‐term disability in multiple sclerosis
Fisniku, L. K., Chard, D. T., Jackson, J. S., Anderson, V. M., Altmann, D. R., Miszkiel, K. A., Thompson, A. J., & Miller, D. H. (2008) · Annals of Neurology · doi:10.1002/ana.21423 · Cited by 500
Macular Segmentation with Optical Coherence Tomography
Ishikawa, H., Stein, D. M., Wollstein, G., Beaton, S., Fujimoto, J. G., & Schuman, J. S. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0335 · Cited by 498
Self-citationGreen, A. J., McQuaid, S., Hauser, S. L., Allen, I. V., & Lyness, R. (2010) · Brain · doi:10.1093/brain/awq080 · Cited by 487
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Barkhof, F., Calabresi, P. A., Miller, D. H., & Reingold, S. C. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.41 · Cited by 378
Self-citationLongitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
Talman, L. S., Bisker, E. R., Sackel, D. J., Long, D. A., Galetta, K. M., Ratchford, J. N., Lile, D. J., Farrell, S. K., Loguidice, M. J., Remington, G., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22005 · Cited by 366
Self-citationMapping of Macular Substructures with Optical Coherence Tomography for Glaucoma Diagnosis
Tan, O., Li, G., Lu, A. T.-H., Varma, R., & Huang, D. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.08.011 · Cited by 361
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
Gunnarsson, M., Malmeström, C., Axelsson, M., Sundström, P., Dahle, C., Vrethem, M., Olsson, T., Piehl, F., Norgren, N., Rosengren, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22247 · Cited by 345
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography
Saidha, S., Syc, S. B., Ibrahim, M. A., Eckstein, C., Warner, C. V., Farrell, S. K., Oakley, J. D., Durbin, M. K., Meyer, S. A., Balcer, L. J., et al. (2011) · Brain · doi:10.1093/brain/awq346 · Cited by 333
Self-citationA topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions
Shiee, N., Bazin, P.-L., Ozturk, A., Reich, D. S., Calabresi, P. A., & Pham, D. L. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.09.005 · Cited by 331
Self-citationSaidha, S., Syc, S. B., Durbin, M. K., Eckstein, C., Oakley, J. D., Meyer, S. A., Conger, A., Frohman, T. C., Newsome, S., Ratchford, J. N., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511418630 · Cited by 296
Self-citationHow Sensitive to Clinical Change are ETDRS logMAR Visual Acuity Measurements?
Rosser, D. A., Cousens, S. N., Murdoch, I. E., Fitzke, F. W., & Laidlaw, D. A. H. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1100 · Cited by 264
Henderson, A. P. D., Trip, S. A., Schlottmann, P. G., Altmann, D. R., Garway-Heath, D. F., Plant, G. T., & Miller, D. H. (2007) · Brain · doi:10.1093/brain/awm285 · Cited by 239
Sung, K. R., Wollstein, G., Bilonick, R. A., Townsend, K. A., Ishikawa, H., Kagemann, L., Noecker, R. J., Fujimoto, J. G., & Schuman, J. S. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.01.004 · Cited by 228
Self-citationImaging Cortical Lesions in Multiple Sclerosis With Ultra–High-Field Magnetic Resonance Imaging
Pitt, D., Boster, A., Pei, W., Wohleb, E., Jasne, A., Zachariah, C. R., Rammohan, K., Knopp, M. V., & Schmalbrock, P. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.148 · Cited by 210
Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis
Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D. C., & Rostami, A. (2010) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e3181f7f833 · Cited by 203
Burkholder, B. M., Osborne, B., Loguidice, M. J., Bisker, E., Frohman, T. C., Conger, A., Ratchford, J. N., Warner, C., Markowitz, C. E., Jacobs, D. A., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.230 · Cited by 199
Self-citationThe National Eye Institute Visual Function Questionnaire: Experience of the ONTT
Long, D. T., Beck, R. W., Gal, R. L., Cole, S. R., & Moke, P. S. (2000) · PubMed · doi:10.17615/6wyq-7w66 · Cited by 194
Visual acuity as an outcome measure in clinical trials of retinal diseases
Beck, R. W., Maguire, M. G., Bressler, N. M., Glassman, A. R., Lindblad, A. S., & Ferris, F. L. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.06.047 · Cited by 188
Self-citationOptical Coherence Tomography (OCT): Imaging the Visual Pathway as a Model for Neurodegeneration
Galetta, K. M., Calabresi, P. A., Frohman, E. M., & Balcer, L. J. (2011) · Neurotherapeutics · doi:10.1007/s13311-010-0005-1 · Cited by 185
Self-citationAxonal degeneration in multiple sclerosis: The mitochondrial hypothesis
Su, K., Banker, G. A., BOURDETTE, D. N., & Forte, M. A. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0060-3 · Cited by 175
Intracortical lesions: Relevance for new MRI diagnostic criteria for multiple sclerosis
Filippi, M., Rocca, M. A., Calabrese, M., Sormani, M. P., Rinaldi, F., Perini, P., Comi, G., & Gallo, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ff96f6 · Cited by 172
Balcer, L. J., Baier, M. L., Pelak, V. S., Fox, R. J., Shuwairi, S., Galetta, S. L., Cutter, G. R., & Maguire, M. G. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600305 · Cited by 163
Self-citationMowry, E. M., Loguidice, M. J., Daniels, A. B., Jacobs, D. A., Markowitz, C., Galetta, S. L., Nano-Schiavi, M. L., Cutter, G., Maguire, M. G., & Balcer, L. J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.165449 · Cited by 135
Self-citationChard, D., & Miller, D. H. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.01.012 · Cited by 130
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
Balcer, L. J., Galetta, S. L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Havrdová, E., Hutchinson, M., Kappos, L., LUBLIN, F. D., Miller, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000259521.14704.a8 · Cited by 129
Self-citationValidation and Test Characteristics of a 10-Item Neuro-Ophthalmic Supplement to the NEI-VFQ-25
Raphael, B. A., Galetta, K. M., Jacobs, D. A., Markowitz, C., Liu, G. T., Nano-Schiavi, M. L., Galetta, S. L., Maguire, M. G., Mangione, C. M., GLOBE, D. R., et al. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.06.060 · Cited by 116
Self-citationReproducibility of high-resolution optical coherence tomography in multiple sclerosis
Syc‐Mazurek, S. B., Warner, C. V., Hiremath, G. S., Farrell, S. K., Ratchford, J. N., Conger, A., Frohman, T. C., Cutter, G., Balcer, L. J., Frohman, E. M., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510371640 · Cited by 114
Self-citationWerner, J. S., Keltner, J. L., Zawadzki, R. J., & Choi, S. S. (2011) · Eye · doi:10.1038/eye.2010.218 · Cited by 84
GLOBE, D. R. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.02.003 · Cited by 83
Reproducibility of Optical Coherence Tomography in Multiple Sclerosis
Saylor, D. R., Pulicken, M., Gordon‐Lipkin, E. M., Salter, A. R., Frohman, T. C., Conger, A., Zhang, X., Cutter, G., Balcer, L. J., Frohman, E. M., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.9.1218 · Cited by 82
Self-citationDavies, E. C., Galetta, K. M., Sackel, D. J., Talman, L. S., Frohman, E. M., Calabresi, P. A., Galetta, S. L., & Balcer, L. J. (2011) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318221b434 · Cited by 67
Self-citationSubmacular Surgery Trials Research Group (2007) · Ophthalmic Epidemiology · doi:10.1080/09286580701502970 · Cited by 63
Zheng, J., & Bizzozero, O. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07182.x · Cited by 40
Merle, H., Olindo, S., Donnio, A., Beral, L., Richer, R., Smadja, D., & Cabre, P. (2010) · European Journal of Ophthalmology · doi:10.1177/112067211002000122 · Cited by 28
Retinal architecture predicts pupillary reflex metrics in MS
Salter, A. R., Conger, A., Frohman, T. C., Zivadinov, R., Eggenberger, E., Calabresi, P. A., Cutter, G., Balcer, L. J., & Frohman, E. M. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508100503 · Cited by 24
Self-citation
Cited by
Toosy, A. T., Mason, D. F., & Miller, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70259-x · Cited by 617
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Petzold, A., Balcer, L. J., Calabresi, P. A., Costello, F., Frohman, T. C., Frohman, E. M., Martinez-Lapiscina, E. H., Green, A. J., Kardon, R., Outteryck, O., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30278-8 · Cited by 585
Self-citationArginase: A Multifaceted Enzyme Important in Health and Disease
Caldwell, R. W., Rodriguez, P. C., Toque, H. A., Narayanan, S. P., & Caldwell, R. B. (2018) · Physiological Reviews · doi:10.1152/physrev.00037.2016 · Cited by 495
Arginase: an old enzyme with new tricks
Caldwell, R. B., Toque, H. A., Narayanan, S. P., & Caldwell, R. W. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.006 · Cited by 332
Saidha, S., Sotirchos, E. S., Ibrahim, M. A., Crainiceanu, C. M., Gelfand, J. M., Sepah, Y. J., Ratchford, J. N., Oh, J., Seigo, M. A., Newsome, S. D., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70213-2 · Cited by 299
Self-citation
Metadata
- Authors
- Walter, S. D., Ishikawa, H., Galetta, K. M., Sakai, R. E., Feller, D. J., Henderson, S. B., Wilson, J. A., Maguire, M. G., Galetta, S. L., Frohman, E., Calabresi, P. A., Schuman, J. S., & Balcer, L. J.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 119
- Issue
- 6
- Pages
- 1250-1257
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2150727535
- Cited by
- 294
- References
- 41
- FWCI
- 23.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.